ARX

Accelerant Holdings Financials Insurance Agents, Brokers & Service Russell 3000
$19.82Close $9.36 – $19.8852-week range Nov 11, 2026Next report

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 95 · stronger than 95% of stocks over 12 months
  • Near its high at its 52-week high
  • Volume drying up last 10 days 38% under the 50-day average
  • Earnings growing EPS +752% year on year

Cautions

  • Results soon Nov 11, 2026, in 10 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 13, 2026
Off 12-month high 0%
1wk up 0.3% price change
1mo up 0.5% price change
12-month return up 75% market up 11% · its own up 58%
F-score — — Not assessed
Altman Z — Unknown
P/E — price / earnings
PEG — P/E / EPS growth
P/B — price / book
Earnings yield — EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 51% year on year
EPS growth up 752% latest quarter
Sales growth up 63% latest quarter · +9 pts
ROE down 269% return on equity
Free cash margin —
D/E 0.17 long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest

Trade setup

ATR% 0.4% $0.08 a day · 2×ATR $19.66
RS 95 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.3× vs 50-day average
Up/down volume 1.32 50 sessions
Implied move — no option chain · report Nov 11, 2026
Trend template · 8 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • No material dilution
  • Margins and revenue not shrinking
Last reported Aug 13, 2026
Last shock Jul 29, 2026-16% in one session2.0× volumeno filing matched+60% since

Financials

3 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $912.9M +51% on FY2024
$0 $1B FY23 FY24 FY25 FY2023 · $344.0M FY2024 · $602.6M FY2025 · $912.9M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$1.3B down to a loss
-$2B $0 FY23 FY24 FY25 FY2023 · -$64.1M FY2024 · $22.9M FY2025 · -$1.3B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net -147%
-200% 0% FY23 FY24 FY25 FY2023 · Net -19% FY2024 · Net 4% FY2025 · Net -147%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $2B FY23 FY24 FY25 FY2023 · Cash $775.4M FY2024 · Cash $1.2B · Long-term debt $121.4M FY2025 · Cash $1.7B · Long-term debt $121.3M
  FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $344.0M $602.6M $912.9M
Net income -$64.1M $22.9M -$1.3B
Net margin -19% 4% -147%
Earnings per share -$0.39 $0.11 -$7.07
Cash $775.4M $1.2B $1.7B
Long-term debt — $121.4M $121.3M
Shareholders' equity $286.7M $304.3M $697.7M
Shares outstanding — 166.19m —

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 13, 2026 Quarterly ↗ Jun 30, 2026 44d
May 13, 2026 Quarterly ↗ Mar 31, 2026 43d
Mar 18, 2026 Annual ↗ Dec 31, 2025 77d
Nov 12, 2025 Quarterly ↗ Sep 30, 2025 43d
Aug 28, 2025 Quarterly ↗ Jun 30, 2025 59d

Current reports